Radiomics-Based Phenotyping for Treatment Optimization of HER2+ Breast Cancer A second Ignition Award is going to ... Launching a Multiplex BRCA1/RAD51C ddPCR Methylation Assay as a Clinical HRD Test ...

Previous work from other laboratories showed that PARP inhibitors are particularly toxic to cells with defects in the homologous recombination (HR) repair pathway, including breast and ... resistance ...

For cancer-suppressor genes like BRCA1, researchers have long hypothesized that a single healthy copy could still guard ...

Under this two-hit model, Brugge says, one normal copy of BRCA1 ought to be able to carry out DNA repair even when the other ...

A Michigan State University researcher's new model for studying breast cancer could help scientists better understand why and ...

GE HealthCare partners with DeepHealth to enhance AI-driven imaging, improving breast cancer screening with SmartMammo. Collaboration aims to streamline workflows and improve early detection through ...

Mabel Mardones, MD, Rocky Mountain Cancer Centers, discusses the future of HR+/HER2– breast cancer treatment, focusing on the importance of biomarkers and the potential of SIRDs to improve patient ...

A new genetic study from researchers at Michigan State University could help scientists gain a deeper understanding of where ...

There are processes in the human body that can suppress the growth and proliferation of cancer cells. These mechanisms, ...

Breast cancer treatments, while life-saving, can impact a woman's fertility. Chemotherapy and radiation therapy, in particular, can damage ovarian function, leading to difficulties conceiving.

Yale study reveals cultural influences in breast cancer surgery decisions, focusing on challenges faced by women of color post-mastectomy.